Research map: Cardiovascular Care in Multiple Myeloma: A Comprehensive Review and Integrated Systems-Based Approach from a UK Cardio-Oncology Centre of Excellence

Back to the article

Papers in this map

  1. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) · Alexander Richard Lyon · 2022 · 3064 citations · Cited by this paper
  2. Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications · 2026 · Related
  3. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma · Robert A. Kyle · 2003 · 2461 citations · Cited by this paper
  4. Global Burden of Cardiovascular Disease: What Should Be Expected in the Next 25 Years? · 2026 · Related
  5. Mortality due to cancer treatment delay: systematic review and meta-analysis · Timothy Paul Hanna · 2020 · 1754 citations · Cited by this paper
  6. Precision Medicine for Anticoagulation Strategies in the Cath Lab: Part 1 · 2026 · Related
  7. Teclistamab in Relapsed or Refractory Multiple Myeloma · Philippe Moreau · 2022 · 1248 citations · Cited by this paper
  8. Enhancing Fetal Cardiac Care: Addressing Unwarranted Variation in Prenatal Congenital Heart Disease Detection and Counseling · 2026 · Related
  9. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases · Pablo García‐Pavía · 2021 · 1229 citations · Cited by this paper
  10. Diagnostic Tests for Stage B Heart Failure · 2026 · Related
  11. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial · S. Vincent Rajkumar · 2009 · 945 citations · Cited by this paper
  12. Race and Patient-Physician Communication on Blood Pressure Management: Helping Improve Care · 2026 · Related
  13. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma · Jesús F. San Miguel · 2023 · 822 citations · Cited by this paper
  14. Combination Lipid-Lowering Therapy After ACS: Should this be the New Standard of Care? · 2026 · Related
  15. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma · Paula Rodríguez‐Otero · 2023 · 775 citations · Cited by this paper
  16. Interventional Strategies for Pulmonary Artery Stenosis After the Arterial Switch Operation · 2026 · Related
  17. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association · Michelle Maya Kittleson · 2020 · 754 citations · Cited by this paper
  18. Survey of Board-Certified Adult Congenital Heart Disease Providers Assessing Workforce Gaps · 2026 · Related
  19. Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma · Ajai Chari · 2022 · 725 citations · Cited by this paper
  20. Echocardiography in cardio-oncology: optimising service delivery · 2026 · Related
  21. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis · Marianna Fontana · 2015 · 627 citations · Cited by this paper
  22. Systemic immunoglobulin light chain amyloidosis · Giampaolo Merlini · 2018 · 573 citations · Cited by this paper
  23. Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma · Donna Weber · 2002 · 569 citations · Cited by this paper
  24. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis · Ashutosh D. Wechalekar · 2013 · 529 citations · Cited by this paper
  25. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management · S. Vincent Rajkumar · 2024 · 496 citations · Cited by this paper
  26. Systemic Amyloidosis Recognition, Prognosis, and Therapy · Morie Abraham Gertz · 2020 · 375 citations · Cited by this paper
  27. A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies · Francis Joseph Giles · 2006 · 314 citations · Cited by this paper
  28. Carfilzomib-Associated Cardiovascular Adverse Events · Adam Justin Waxman · 2017 · 284 citations · Cited by this paper
  29. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma · Thierry T.F. Facon · 2024 · 278 citations · Cited by this paper
  30. Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology · Eve Belzile‐Dugas · 2021 · 273 citations · Cited by this paper
  31. Current status of autologous stem cell transplantation for multiple myeloma · Rama Al Hamed · 2019 · 237 citations · Cited by this paper
  32. Anthracycline Cardiotoxicity in Adult Cancer Patients · Massimiliano Camilli · 2024 · 216 citations · Cited by this paper
  33. International Myeloma Working Group recommendations for global myeloma care · Heinz Ludwig · 2013 · 208 citations · Cited by this paper
  34. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis · Jonathan A. Pan · 2020 · 172 citations · Cited by this paper
  35. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study · Andrew Staron · 2021 · 149 citations · Cited by this paper
  36. Activity and Outcomes of a Cardio-Oncology Service in the United Kingdom—A Five-Year Experience · Nilesh Pareek · 2018 · 145 citations · Cited by this paper
  37. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial · Meletios Athanasios Dimopoulos · 2018 · 142 citations · Cited by this paper
  38. Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis · Peter R. Huntjens · 2021 · 119 citations · Cited by this paper
  39. Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies · Georgios A. Georgiopoulos · 2023 · 115 citations · Cited by this paper

Source: OpenAlex (CC0)